Brief: Medigene And Roivant Affiliate Cytovant Establish Strategic Partnership

Medigene AG

04/04/2019 11:39

April 4 (Reuters) - Medigene AG  MDG1k.DE :
    * PTA-ADHOC: MEDIGENE AG: MEDIGENE AND ROIVANT AFFILIATE
CYTOVANT
ESTABLISH STRATEGIC RESEARCH AND DEVELOPMENT PARTNERSHIP FOR
CELLULAR THERAPIES IN ASIA
    * MEDIGENE WILL RECEIVE AN OVERALL UPFRONT PAYMENT OF USD 10
MILLION AS WELL AS POTENTIAL DEVELOPMENT
    * MEDIGENE WILL BE ELIGIBLE TO RECEIVE ROYALTY PAYMENTS ON
NET
SALES OF PRODUCTS IN A LOW DOUBLE-DIGIT PERCENTAGE IN RELEVANT
COUNTRIES
    * CYTOVANT WILL REIMBURSE ALL RESEARCH AND DEVELOPMENT COSTS
INCURRED BY MEDIGENE WITHIN COLLABORATION.
    * TO RECEIVE COMMERCIAL MILESTONE PAYMENTS WHICH IN
AGGREGATE
COULD TOTAL OVER USD 1 BILLION

Source text for Eikon:  ID:nPexdJzDla 
Further company coverage:  MDG1k.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))